Skip to main content
Premium Trial:

Request an Annual Quote

Oncocyte: John Peter Gutfreund

Oncocyte's board of directors has elected John Peter Gutfreund as a new independent director, with a term that expires at the company's 2023 annual stockholder meeting or until his earlier resignation or removal. Gutfreund, who will chair the board's finance committee and will serve on its compensation committee, has served as managing Partner of Halle Capital Management since October 2019. He also serves on the board of several Halle portfolio companies and is a trustee at Montefiore Health System. Prior to joining Halle Capital Management, Gutfreund was director of research at Glenview Capital Management, He holds a BA from New York University.